Phase II study of radiochemotherapy with UFT and low-dose oral leucovorin in patients with unresectable rectal cancer.

MLA

de la Torre, A., et al. “Phase II Study of Radiochemotherapy with UFT and Low-Dose Oral Leucovorin in Patients with Unresectable Rectal Cancer.” International Journal of Radiation Oncology, Biology, Physics, vol. 45, no. 3, Oct. 1999, pp. 629–34. EBSCOhost, https://doi.org/10.1016/s0360-3016(99)00225-4.

APA

de la Torre, A., Ramos, S., Valcárcel, F. J., Candal, A., Regueiro, C. A., Romero, J., Magallón, R., Salinas, J., de las Heras, M., Veiras, C., Tisaire, J. L., & Aragón, G. (1999). Phase II study of radiochemotherapy with UFT and low-dose oral leucovorin in patients with unresectable rectal cancer. International Journal of Radiation Oncology, Biology, Physics, 45(3), 629–634. https://doi.org/10.1016/s0360-3016(99)00225-4

Chicago

de la Torre, A, S Ramos, F J Valcárcel, A Candal, C A Regueiro, J Romero, R Magallón, et al. 1999. “Phase II Study of Radiochemotherapy with UFT and Low-Dose Oral Leucovorin in Patients with Unresectable Rectal Cancer.” International Journal of Radiation Oncology, Biology, Physics 45 (3): 629–34. doi:10.1016/s0360-3016(99)00225-4.